comparemela.com

Latest Breaking News On - Hebron campus - Page 1 : comparemela.com

Study identifies a novel regulator of dormant cancer cells and chemoresistance in colorectal cancer

Study identifies a novel regulator of dormant cancer cells and chemoresistance in colorectal cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

The promise of novel FolRα-targeting antibody

Presented today by VHIO’s Ana Oaknin at the 2023 ASCO Annual Meeting, 2-6 June (Chicago, IL), updated dose expansion data of the STRO-002-GM1 global phase I study show promise of FolRα-targeting antibody drug conjugate (ADC) luveltamab tazevibulin in patients with recurrent FolRα-expressing epithelial ovarian cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.